May 23, 2017
1 min read
Save

Significant improvements seen in accelerometer-measured physical activity after lumbar spine surgery

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Results of this study that used accelerometers to measure physical activity showed patients who underwent lumbar decompression and fusion had statistically significant improvements in physical activity; however, researchers found no significant association between the improvements in physical activity and clinical outcome scores.

Ralph J. Mobbs, MD, and colleagues performed a prospective study of 30 patients who underwent lumbar spine surgery. Of these patients, 28 completed accelerometer-tracked physical activity and clinical follow-up. Investigators used a Fitbit accelerometer (Fitbit Inc.) to assess physical performance. A Fitbit activity monitor recorded preoperative and postoperative average physical activity, which included parameters such as the number of steps taken, distance traveled and calories burned. Self-reported outcome scores included the VAS, the Oswestry Disability Index (ODI) and SF-12 mental and physical component summary scores.

Ralph J. Mobbs

At the 3-month follow-up, the mean number of steps taken per day increased by 58.2% and the mean distance traveled per day increased by 63%. Investigators noted significant improvements for the mean change in VAS back pain and leg pain and for the SF-12 physical component summary scores. At follow-up, investigators found no significant association between the steps or distance traveled per day and improvements observed in VAS back pain or leg pain, ODI or physical component summary scores. – by Monica Jaramillo

Disclosures: Mobbs reports he is on the speakers bureau for Stryker Spine and Synthes, receives royalties from Stryker Spine, has stock/stock options in Medtronic and Johnson & Johnson, and has meeting expenses paid by Orthotec.